Detalhe da pesquisa
1.
AD and its comorbidities: An obstacle to develop a clinically efficient treatment?
Rev Neurol (Paris);
178(5): 450-459, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35513932
2.
Not all voxels are created equal: Reducing estimation bias in regional NODDI metrics using tissue-weighted means.
Neuroimage;
245: 118749, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34852276
3.
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.
J Intern Med;
290(3): 583-601, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021943
4.
Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series.
Mol Psychiatry;
25(12): 3399-3412, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30279455
5.
Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience.
JRSM Open;
9(9): 2054270418793021, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30202534
6.
Alzheimer's disease.
Eur J Neurol;
25(1): 59-70, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28872215
7.
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.
Transl Psychiatry;
6(11): e952, 2016 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27845782
8.
Rapid processing of PET list-mode data for efficient uncertainty estimation and data analysis.
Phys Med Biol;
61(13): N322-36, 2016 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27280456
9.
EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease.
Eur J Neurol;
22(6): 889-98, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25808982
10.
A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes.
J Neurol Neurosurg Psychiatry;
86(11): 1240-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25589779
11.
Phenotypical variation in Alzheimer's disease: insights from posterior cortical atrophy.
Pract Neurol;
15(1): 2-4, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25239627
12.
Infection, inflammation and Alzheimer's disease.
Eur J Neurol;
22(12): 1503-4, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25039413
13.
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.
J Neurol;
262(1): 228-34, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25488473
14.
Biomarkers in dementia: clinical utility and new directions.
J Neurol Neurosurg Psychiatry;
85(12): 1426-34, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25261571
15.
Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.
Transl Psychiatry;
4: e419, 2014 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25072324
16.
A practical approach to diagnosing adult onset leukodystrophies.
J Neurol Neurosurg Psychiatry;
85(7): 770-81, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24357685
17.
CSF biomarkers for Alzheimer's pathology and the effect size of APOE É4.
Mol Psychiatry;
19(2): 148-9, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23419830
18.
Primary progressive aphasia: defining genetic and pathological subtypes.
Curr Alzheimer Res;
8(3): 266-72, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21222598
19.
Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.
Neurobiol Aging;
31(8): 1452-62, 1462.e1-2, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20620665
20.
Neuropsychological correlates of whole brain atrophy in Alzheimer's disease.
Neuropsychologia;
46(6): 1732-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18395233